Neurim not fit for purpose, but are SPCs?
On 9 July 2020, the CJEU followed the Advocate General’s recommendation in Santen (see Is Neurim fit for purpose? Santen AGO on SPCs for...
Sarah has experience of a range of contentious and non-contentious IP, IT, data protection and commercial work.
On 9 July 2020, the CJEU followed the Advocate General’s recommendation in Santen (see Is Neurim fit for purpose? Santen AGO on SPCs for...
The Neurim decision opened the door for obtaining SPCs for second medical use patents. Although welcomed by innovators, the judgment was...
On 6 March 2018, the UK government published a technical note on its approach to certain separation issues that are to be agreed as part...
On Wednesday, the European Commission (EC) issued guidance on the licensing of standard essential patents (SEPs), being patents that...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net